Authors:
MAH SJ
TANG YM
LIAUW PE
NAGEL JE
SCHNEIDER AS
Citation: Sj. Mah et al., IBOGAINE ACTS AT THE NICOTINIC ACETYLCHOLINE-RECEPTOR TO INHIBIT CATECHOLAMINE RELEASE, Brain research, 797(1), 1998, pp. 173-180
Citation: As. Schneider et al., ANOPHTHALMIA MICROPHTHALMIA REGISTRY - REVIEW OF 41 CASES/, American journal of human genetics, 61(4), 1997, pp. 629-629
Authors:
SCHNEIDER AS
BISCHOFF FZ
MCCASKILL C
COADY ML
STOPFER JE
SHAFFER LG
Citation: As. Schneider et al., COMPREHENSIVE 4-YEAR FOLLOW-UP ON A CASE OF MATERNAL HETERODISOMY FORCHROMOSOME-16, American journal of medical genetics, 66(2), 1996, pp. 204-208
Citation: As. Schneider et al., IBOGAINE SELECTIVELY INHIBITS NICOTINIC RECEPTOR-MEDIATED CATECHOLAMINE RELEASE, European journal of pharmacology, 317(2-3), 1996, pp. 1-2
Citation: Sa. Factor et As. Schneider, PERIPHERAL CATECHOLAMINE OUTPUT IN PARKINSONS-DISEASE - EFFECTS OF DRUG-TREATMENT, Experimental neurology, 131(1), 1995, pp. 64-68
Citation: Ae. Bullock et As. Schneider, ADAPTIVE-MECHANISMS ASSOCIATED WITH CHRONIC NICOTINE TOLERANCE AND WITHDRAWAL IN BOVINE ADRENAL CHROMAFFIN CELLS, The FASEB journal, 8(7), 1994, pp. 10001408-10001408
Citation: Ae. Bullock et al., NICOTINE TOLERANCE IN CHROMAFFIN CELL-CULTURES - ACUTE AND CHRONIC EXPOSURE TO SMOKING-RELATED NICOTINE DOSES, Journal of neurochemistry, 62(5), 1994, pp. 1863-1869